Adults who have learning difficulties often face big problems when it comes to joining new medical studies that try to match treatments to a person’s genes and lifestyle. These studies could help everyone, especially those who normally get less fair care. But the rules about whether a person w
These tiny 3‑D cultures, called organoids, are changing how scientists study lung cancer. Instead of flat cell sheets or animal models that take months to grow, organoids can be produced quickly while keeping the original tumor’s structure and variety. Researchers now grow lung cancer organoid
Healthcare has always been a bit of a slow mover. Why? Well, it's complicated, heavily regulated, and safety is a top priority. But guess what? Things are starting to change. Over the past ten years, tech has been advancing, people's expectations have shifted, and new rules have been put in place.
Tuberculosis is a tough nut to crack. Doctors need to understand the patient's unique profile to treat it effectively. This includes looking at their health background, the severity of the disease, the amount of bacteria present, how the bacteria respond to drugs, and the patient's immune response.
A fresh startup in Albuquerque has just landed a cool $2. 5 million to shake up the world of DNA and RNA sequencing. This isn't just any tech—it's the kind that could change how we tackle diseases, from custom cancer treatments to predicting health risks. The brains behind Daisy Genomics, Emily Mil
A cutting-edge company is teaming up with a big pharma player to tackle a growing health problem. The focus? A serious liver condition called MASH, which is linked to obesity and diabetes. The plan is to use smart blood tests to find better ways to treat it. The company, Mursla Bio, is known for it
Acute myeloid leukemia (AML) is a tough opponent, but stem cell transplants can be a game-changer for many patients. Over the last ten years, doctors have gotten better at spotting who might not do well after a transplant. This is thanks to new predictive tools that help tailor treatments to each pe
The world of medicine is always looking for better ways to treat diseases. One exciting area is smart drug delivery. This is where drugs are released only when certain conditions are met in the body. This approach is especially useful for blood-related diseases. These smart systems work by reacting
Sepsis is a serious condition that happens when an infection causes organ failure. It's tricky to treat because it affects people differently. This makes it a tough nut to crack for doctors trying to give precise care in critical situations. The stakes are high, with many patients not surviving thei
Type 2 diabetes is a tough opponent. Once metformin is no longer enough, doctors have to pick between three other types of pills to help manage blood sugar. The choices are sulfonylureas, DPP4 inhibitors, and SGLT2 inhibitors. But how do doctors know which one will work best for each person? Thi
